Sarcopenia is a geriatric condition characterized by a progressive loss of skeletal muscle
mass and strength, with an increased risk of adverse health outcomes (eg, falls, disability …

Increased life expectancy, attributed to improved access to healthcare and drug
development, has led to an increase in multimorbidity, a key contributor to polypharmacy …

Objective To map out the studies that have investigated the associations of polypharmacy
and/or potentially inappropriate medication (PIM) use with physical activity and sedentary …

Background Polypharmacy is one of the most important health issues for its potential
impacts on disease burden and healthcare costs. The aim of this study was to update a …

Background Deprescribing is essential for reducing inappropriate medication use and
polypharmacy. For a holistic approach, it is essential to know how older adult patients and …

Multimorbidity (multiple conditions) and polypharmacy (multiple medications) are
increasingly common, yet there is a need to better understand the prevalence of co …

The simultaneous use of multiple drugs—termed 'polypharmacy'—is often required to
manage multiple physiological and biological changes and the interplay between chronic …

Abstract Purpose of Review Polypharmacy, the use of≥ 5 medications, is common in people
with multiple sclerosis and is associated with negative outcomes. The use of multiple …

Polypharmacy, and the negative effects that can arise from it, is increasingly recognised as
an issue by healthcare systems globally. Although there is currently no consensus on the …

Deprescribing has recently been applied to address polypharmacy, particularly among older
adults. However, the characteristics of deprescribing that are likely to improve health …